日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML

SGN-CD33A:一种使用吡咯并苯二氮卓二聚体的新型 CD33 靶向抗体-药物偶联物,在耐药性 AML 模型中具有活性

May S Kung Sutherland, Roland B Walter, Scott C Jeffrey, Patrick J Burke, Changpu Yu, Heather Kostner, Ivan Stone, Maureen C Ryan, Django Sussman, Robert P Lyon, Weiping Zeng, Kimberly H Harrington, Kerry Klussman, Lori Westendorf, David Meyer, Irwin D Bernstein, Peter D Senter, Dennis R Benjamin, J

5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia

5-氮杂胞苷增强林妥珠单抗 (SGN-33) 在急性髓系白血病临床前模型中的抗白血病活性

May Kung Sutherland, Changpu Yu, Martha Anderson, Weiping Zeng, Nico van Rooijen, Eric L Sievers, Iqbal S Grewal, Che-Leung Law

Anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia

林妥珠单抗(SGN-33)在急性髓系白血病临床前模型中的抗白血病活性

May Kung Sutherland, Changpu Yu, Timothy S Lewis, Jamie B Miyamoto, Carol A Morris-Tilden, Mechthild Jonas, Jennifer Sutherland, Albina Nesterova, Hans-Peter Gerber, Eric L Sievers, Iqbal S Grewal, Che-Leung Law

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

骨细胞通过新型 BMP 拮抗剂硬化蛋白控制骨形成

David G Winkler, May Kung Sutherland, James C Geoghegan, Changpu Yu, Trenton Hayes, John E Skonier, Diana Shpektor, Mechtild Jonas, Brian R Kovacevich, Karen Staehling-Hampton, Mark Appleby, Mary E Brunkow, John A Latham